Dopaminergic Neuron cell therapy (BlueRock)

N/A

Report date: 2024/09/03 10:06:45

Base Information

Drug NameDopaminergic Neuron cell therapy (BlueRock)
Drug Alias NameBR-DA02BRDA-02DA-02
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Induced pluripotent stem cells therapy
Mechanisms of ActionDopaminergic cell replacements
TargetsUpdating
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBluerock Therapeutics Lp
China Registration ClassN/A

Develop Information

Active CompaniesBluerock Therapeutics Lp
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A